BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol. 2002;17:526-534. [PMID: 12084024 DOI: 10.1046/j.1440-1746.2002.02764.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Thomas C, Schiano TD, Thung SN, Ward SC, Fiel MI. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy. Histopathology 2020;76:959-67. [PMID: 31994248 DOI: 10.1111/his.14083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maruyama H, Kondo T, Sekimoto T, Yokosuka O. Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal Hypertension. Medicine (Baltimore) 2015;94:e1056. [PMID: 26131820 DOI: 10.1097/MD.0000000000001056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tyagi P, Puri AS, Sachdeva S. Spontaneous air in the main pancreatic duct. Indian J Gastroenterol. 2009;28:87. [PMID: 19907955 DOI: 10.1007/s12664-009-0030-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
4 Chakraborty D, Sunil HV, Mittal BR, Bhattacharya A, Singh B, Chawla Y. Role of Tc99m sulfur colloid scintigraphy in differentiating non-cirrhotic portal fibrosis from cirrhosis liver. Indian J Nucl Med 2010;25:139-42. [PMID: 21713221 DOI: 10.4103/0972-3919.78247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398-413. [PMID: 19669336 DOI: 10.1007/s12072-007-9010-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
6 Seijo S, Lozano JJ, Alonso C, Miquel R, Berzigotti A, Reverter E, Turon F, Martínez-chantar ML, Castro A, Mato JM, Hernández-gea V, Bosch J, García-pagán JC. Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension. Liver Int 2016;36:1051-8. [DOI: 10.1111/liv.12972] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
7 Mackie I, Eapen CE, Neil D, Lawrie AS, Chitolie A, Shaw JC, Elias E. Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency. Dig Dis Sci. 2011;56:2456-2465. [PMID: 21573942 DOI: 10.1007/s10620-011-1729-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
8 Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, Chen J, Srour SA, Bashir Q, Rondon G, Oran B, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Marin D, Khouri IF, Ciurea SO, Qazilbash MH, Rezvani K, Anderlini P, Andersson BS, Shpall EJ, Champlin RE, Popat UR. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 2020;4:1296-306. [PMID: 32236526 DOI: 10.1182/bloodadvances.2019000638] [Reference Citation Analysis]
9 Schouten JN, Verheij J, Seijo S. Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis. 2015;10:67. [PMID: 26025214 DOI: 10.1186/s13023-015-0288-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
10 Francque S, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Van Gaal L, Michielsen P. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur J Gastroenterol Hepatol. 2010;22:1449-1457. [PMID: 21389796 DOI: 10.1097/meg.0b013e32833f14a1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
11 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Gupta S, Pottakkat B, Verma SK, Kalayarasan R, Chandrasekar A S, Pillai AA. Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension. World J Gastrointest Surg 2020; 12(1): 1-8 [PMID: 31984119 DOI: 10.4240/wjgs.v12.i1.1] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
13 Maruyama H, Kondo T, Sekimoto T, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? Eur J Gastroenterol Hepatol. 2015;27:321-327. [PMID: 25563140 DOI: 10.1097/meg.0000000000000268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Hoseinzadeh S, Shafiei B, Salehian M, Neshandar Asli I, Ghodoosi I. Huge Varicose Inferior Mesenteric Vein: an Unanticipated (99m) Tc-labeled Red Blood Cell Scintigraphy Finding. Nucl Med Mol Imaging 2010;44:217-22. [PMID: 24899953 DOI: 10.1007/s13139-010-0033-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kapoor S, Pal S, Sahni P, Chattopadhyay TK. Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non-cirrhotic portal fibrosis: a pilot study. J Gastroenterol Hepatol. 2009;24:992-997. [PMID: 19220674 DOI: 10.1111/j.1440-1746.2008.05761.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
16 Evans WN, Winn BJ, Yumiaco NS, Galindo A, Rothman A, Acherman RJ, Restrepo H. Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization. Pediatr Cardiol 2014;35:1273-8. [PMID: 24817681 DOI: 10.1007/s00246-014-0928-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
17 Weber A, Krebs S, Lenhardt C, Wagenpfeil S, Schmid RM, Schulte-Frohlinde E. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2009;39:882-887. [PMID: 19619258 DOI: 10.1111/j.1872-034X.2009.00531.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ricciardi M. Splenophrenic portosystemic shunt in dogs with and without portal hypertension: can acquired and congenital porto-caval connections coexist? Open Vet J 2016;6:185-93. [PMID: 27882305 DOI: 10.4314/ovj.v6i3.7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Lee H, Rehman AU, Fiel MI. Idiopathic Noncirrhotic Portal Hypertension: An Appraisal. J Pathol Transl Med. 2016;50:17-25. [PMID: 26563701 DOI: 10.4132/jptm.2015.09.23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
20 Murai Y, Ohfuji S, Fukushima W, Tamakoshi A, Yamaguchi S, Hashizume M, Moriyasu F, Hirota Y. Prognostic factors in patients with idiopathic portal hypertension: Two Japanese nationwide epidemiological surveys in 1999 and 2005: Prognostic factors of IPH patients. Hepatology Research 2012;42:1211-20. [DOI: 10.1111/j.1872-034x.2012.01033.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Guido M, Sarcognato S, Russo FP, Cardin R, Piciocchi M, Colloredo G, Farinati F. Focus on histological abnormalities of intrahepatic vasculature in chronic viral hepatitis. Liver Int 2018;38:1770-6. [DOI: 10.1111/liv.13718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
22 Goel A, Ramakrishna B, Muliyil J, Madhu K, Sajith KG, Zachariah U, Ramachandran J, Keshava SN, Selvakumar R, Chandy GM, Elias E, Eapen CE. Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis. Dig Dis Sci 2013;58:179-87. [PMID: 22918688 DOI: 10.1007/s10620-012-2361-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
23 Kumar S, Chandra A. Noncirrhotic Portal Fibrosis in a Young Girl. J Pediatr Gastroenterol Nutr 2019;68:e51. [PMID: 30801396 DOI: 10.1097/MPG.0000000000001870] [Reference Citation Analysis]
24 Dulger AC, Kemik O, Begenik H, Sumer A, Bulut D, Bulut G. Synchronous Esophageal Squamous Cell Carcinoma and Esophageal Variceal Bleeding due to Idiopathic Portal Hypertension: A Case Report. Gastroenterology Res 2011;4:84-7. [PMID: 27942320 DOI: 10.4021/gr300e] [Reference Citation Analysis]
25 Siramolpiwat S, Seijo S, Miquel R, Berzigotti A, Garcia-Criado A, Darnell A, Turon F, Hernandez-Gea V, Bosch J, Garcia-Pagán JC. Idiopathic portal hypertension: natural history and long-term outcome. Hepatology. 2014;59:2276-2285. [PMID: 24155091 DOI: 10.1002/hep.26904] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 11.3] [Reference Citation Analysis]
26 Ricciardi M. Unusual haemodynamics in two dogs and two cats with portosystemic shunt - implications for distinguishing between congenital and acquired conditions. Open Vet J 2017;7:86-94. [PMID: 28616388 DOI: 10.4314/ovj.v7i2.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Snyder P, Ali R, Poles M, Gross SA. Portal hypertensive gastropathy with a focus on management. Expert Rev Gastroenterol Hepatol. 2015;9:1207-1216. [PMID: 26293979 DOI: 10.1586/17474124.2015.1059275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
28 Wu J, Li Z, Wang Z, Han X, Ji F, Zhang WW. Surgical and endovascular treatment of severe complications secondary to noncirrhotic portal hypertension: experience of 56 cases. Ann Vasc Surg. 2013;27:441-446. [PMID: 23465435 DOI: 10.1016/j.avsg.2012.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
29 Seijo S, Reverter E, Miquel R, Berzigotti A, Abraldes JG, Bosch J, García-Pagán JC. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis. 2012;44:855-860. [PMID: 22721839 DOI: 10.1016/j.dld.2012.05.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
30 Nicoară-Farcău O, Rusu I, Stefănescu H, Tanțău M, Badea RI, Procopeț B. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease. World J Gastroenterol 2020; 26(22): 3000-3011 [PMID: 32587444 DOI: 10.3748/wjg.v26.i22.3000] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Rajekar H, Vasishta RK, Chawla YK, Dhiman RK. Noncirrhotic portal hypertension. J Clin Exp Hepatol 2011;1:94-108. [PMID: 25755321 DOI: 10.1016/S0973-6883(11)60128-X] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
32 Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1-10. [PMID: 29064029 DOI: 10.1007/s12072-017-9827-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
33 Sun Y, Lan X, Shao C, Wang T, Yang Z. Clinical features of idiopathic portal hypertension in China: A retrospective study of 338 patients and literature review. J Gastroenterol Hepatol. 2019;34:1417-1423. [PMID: 30462857 DOI: 10.1111/jgh.14552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Krishnan A, Srinivasan V, Venkataraman J. Variceal recurrence, rebleeding rates and alterations in clinical and laboratory parameters following post-variceal obliteration using endoscopic sclerotherapy. J Dig Dis. 2012;13:596-600. [PMID: 23107447 DOI: 10.1111/j.1751-2980.2012.00633.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Maruyama H, Shimada T, Ishibashi H, Takahashi M, Kamesaki H, Yokosuka O. Delayed periportal enhancement: a characteristic finding on contrast ultrasound in idiopathic portal hypertension. Hepatol Int 2012;6:511-9. [DOI: 10.1007/s12072-011-9285-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
36 Krishnan P, Fiel MI, Rosenkrantz AB, Hajdu CH, Schiano TD, Oyfe I, Taouli B. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol. 2012;198:370-376. [PMID: 22268180 DOI: 10.2214/ajr.11.6855] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Jacobi D, de Muret A, Arbeille B, Perarnau JM. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension secondary to non-cirrhotic perisinusoidal hepatic fibrosis. Eur J Gastroenterol Hepatol 2006;18:549-51. [PMID: 16607154 DOI: 10.1097/00042737-200605000-00017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Schouten JNL, Nevens F, Hansen B, Laleman W, den Born M, Komuta M, Roskams T, Verheij J, Janssen HLA. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther 2012;35:1424-33. [DOI: 10.1111/j.1365-2036.2012.05112.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
39 Saigal S, Nayak NC, Jain D, Kumaran V, Mohanka R, Saraf N, Rastogi A, Mehta N, Nundy S, Soin A. Non-cirrhotic portal fibrosis related end stage liver disease in adults: evaluation from a study on living donor liver transplant recipients. Hepatol Int 2011;5:882-9. [PMID: 21484137 DOI: 10.1007/s12072-010-9246-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
40 Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2018;63:563-76. [DOI: 10.1007/s10620-017-4903-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
41 Wani ZA, Bhat RA, Bhadoria AS, Maiwall R. Extrahepatic portal vein obstruction and portal vein thrombosis in special situations: Need for a new classification. Saudi J Gastroenterol 2015;21:129-38. [PMID: 26021771 DOI: 10.4103/1319-3767.157550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
42 Klein S, Hinüber C, Hittatiya K, Schierwagen R, Uschner FE, Strassburg CP, Fischer HP, Spengler U, Trebicka J. Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension. PLoS One 2016;11:e0162144. [PMID: 27589391 DOI: 10.1371/journal.pone.0162144] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
43 Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol. 2005;100:797-804. [PMID: 15784021 DOI: 10.1111/j.1572-0241.2005.40468.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
44 Maruyama H, Ishibashi H, Takahashi M, Imazeki F, Yokosuka O. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. Radiology. 2009;252:587-594. [PMID: 19508988 DOI: 10.1148/radiol.2522081899] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
45 Regnault D, d'Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 2018;30:557-62. [PMID: 29324586 DOI: 10.1097/MEG.0000000000001067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
46 Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics*,**. Diagnosis and treatment guidelines for aberrant portal hemodynamics: The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health, Labor and Welfare of Japan. Hepatol Res. 2017;47:373-386. [PMID: 28058764 DOI: 10.1111/hepr.12862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 孙立平, 童巧霞, 揭盛华. 门静脉高压症少见成因及其诊断. 世界华人消化杂志 2011; 19(35): 3616-3622 [DOI: 10.11569/wcjd.v19.i35.3616] [Reference Citation Analysis]
48 Maruyama H, Okugawa H, Kobayashi S, Yoshizumi H, Takahashi M, Ishibashi H, Yokosuka O. Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis. Br J Radiol. 2012;85:587-595. [PMID: 21343319 DOI: 10.1259/bjr/25522379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
49 Guido M, Sarcognato S, Sacchi D, Colloredo G. Pathology of idiopathic non-cirrhotic portal hypertension. Virchows Arch 2018;473:23-31. [DOI: 10.1007/s00428-018-2355-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
50 Sumana G, Dadhwal V, Deka D, Mittal S. Non-cirrhotic portal hypertension and pregnancy outcome. Journal of Obstetrics and Gynaecology Research 2008;34:801-4. [DOI: 10.1111/j.1447-0756.2008.00853.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
51 Turon F, Silva-Junior G, Hernandez-Gea V, Garcia-Pagan JC. [Idiopathic non-cirrhotic portal hypertension]. Gastroenterol Hepatol 2015;38:556-62. [PMID: 26321321 DOI: 10.1016/j.gastrohep.2015.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
52 Sharma P, Sharma BC, Puri V, Sarin SK. Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction. Am J Gastroenterology 2008;103:1406-12. [DOI: 10.1111/j.1572-0241.2008.01830.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
53 Tanaka T, Sugawara Y, Kokudo N. The current clinical aspects of idiopathic portal hypertension. Intractable Rare Dis Res. 2013;2:94-97. [PMID: 25343110 DOI: 10.5582/irdr.2013.v2.3.94] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
54 Seijo S, Lozano JJ, Alonso C, Reverter E, Miquel R, Abraldes JG, Martinez-Chantar ML, Garcia-Criado A, Berzigotti A, Castro A, Mato JM, Bosch J, Garcia-Pagan JC. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension. Am J Gastroenterol. 2013;108:926-932. [PMID: 23419380 DOI: 10.1038/ajg.2013.11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
55 Sarin SK, Kumar A. Noncirrhotic Portal Hypertension. Clinics in Liver Disease 2006;10:627-51. [DOI: 10.1016/j.cld.2006.08.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
56 Arslan N, Buyukgebiz B, Ozturk Y, Hizli S, Bekem O, Sagol O, Ozer E. Hepatoportal sclerosis in a child. Eur J Pediatr 2004;163:683-4. [PMID: 15316776 DOI: 10.1007/s00431-004-1525-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Verheij J, Schouten JN, Komuta M, Nevens F, Hansen BE, Janssen HL, Roskams T. Histological features in western patients with idiopathic non-cirrhotic portal hypertension. Histopathology. 2013;62:1083-1091. [PMID: 23600724 DOI: 10.1111/his.12114] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
58 Sharma P, Kumar A, Mehta V, Sharma BC, Sarin SK. Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis. Hepatol Int. 2007;1:275-280. [PMID: 19669349 DOI: 10.1007/s12072-007-5006-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
59 Malik ZR, Razaq Z, Siff M, Sheikh S. COVID-19 Presenting as Banti's Syndrome. Cureus 2020;12:e9096. [PMID: 32789044 DOI: 10.7759/cureus.9096] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, Garcia-Pagan JC. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol. 2009;104:1707-1714. [PMID: 19471257 DOI: 10.1038/ajg.2009.165] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
61 Bayan K, Tüzün Y, Yılmaz Ş, Canoruc N, Dursun M. Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension. J Thromb Thrombolysis 2009;28:57-62. [DOI: 10.1007/s11239-008-0244-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
62 Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol. 2007;102:2536-2540. [PMID: 17640321 DOI: 10.1111/j.1572-0241.2007.01428.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
63 Jena P, Sheela CN, Venkatachala RP, Devarbhavi H. Obstetric Outcome in Women with Chronic Liver Disease. J Obstet Gynaecol India 2017;67:263-9. [PMID: 28706365 DOI: 10.1007/s13224-016-0959-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Däbritz J, Worch J, Materna U, Koch B, Koehler G, Duck C, Frühwald MC, Foell D. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol 2010;10:122. [PMID: 20961440 DOI: 10.1186/1471-230X-10-122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
65 Eapen CE, Nightingale P, Hubscher SG, Lane PJ, Plant T, Velissaris D, Elias E. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci. 2011;56:227-235. [PMID: 20499175 DOI: 10.1007/s10620-010-1278-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
66 Geramizadeh B, Malek-hosseini S, Salahi H, Bahador A, Nikeghbalian S. Liver Failure and the Need for Transplantation in Three Patients With Hepatoportal Sclerosis. Transplantation Proceedings 2008;40:3526-8. [DOI: 10.1016/j.transproceed.2008.06.104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Kotani K, Kawabe J, Morikawa H, Akahoshi T, Hashizume M, Shiomi S. Comprehensive Screening of Gene Function and Networks by DNA Microarray Analysis in Japanese Patients with Idiopathic Portal Hypertension. Mediators Inflamm 2015;2015:349215. [PMID: 26549939 DOI: 10.1155/2015/349215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
68 Köksal AS, Köklü S, Ibiş M, Balci M, Ciçek B, Saşmaz N, Sahin B. Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis. Dig Dis Sci 2007;52:3493-8. [PMID: 17404864 DOI: 10.1007/s10620-006-9596-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
69 Aggarwal S, Fiel MI, Schiano TD. Obliterative Portal Venopathy: A Clinical and Histopathological Review. Dig Dis Sci 2013;58:2767-76. [DOI: 10.1007/s10620-013-2736-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
70 Rajalingam R, Javed A, Sharma D, Sakhuja P, Singh S, Nag HH, Agarwal AK. Management of hypersplenism in non-cirrhotic portal hypertension: a surgical series. Hepatobiliary & Pancreatic Diseases International 2012;11:165-71. [DOI: 10.1016/s1499-3872(12)60143-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Sekimoto T, Maruyama H, Kobayashi K, Kiyono S, Kondo T, Shimada T, Takahashi M, Yokosuka O. Well-tolerated portal hypertension and favorable prognosis in adult patients with extrahepatic portal vein obstruction in Japan: Extrahepatic portal vein obstruction in Japan. Hepatol Res 2016;46:505-13. [DOI: 10.1111/hepr.12581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
72 Isabel Fiel M, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver Failure and Need for Liver Transplantation in Patients With Advanced Hepatoportal Sclerosis. American Journal of Surgical Pathology 2007;31:607-14. [DOI: 10.1097/01.pas.0000213425.76621.f1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
73 Lawal TO, Farris AB, El-Rayes BF, Subramanian RM, Kim HS. Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt. Clin Colorectal Cancer. 2012;11:224-227. [PMID: 22537609 DOI: 10.1016/j.clcc.2012.02.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
74 Madhugiri VS, Singh R, Vyavahare M, Vijayahari R, Sasidharan GM, Kuma VR, Jacob S, Verma SK, Ananthakrishnan R, Yadav AK, Gundamaneni SK. Opportunistic Fonsecaea pedrosoi brain abscess in a patient with non-cirrhotic portal fibrosis-induced hypersplenism--a novel association. Br J Neurosurg 2013;27:690-3. [PMID: 23458558 DOI: 10.3109/02688697.2013.771732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Lee H, Ainechi S, Singh M, Ells PF, Sheehan CE, Lin J. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients. Int J Surg Pathol 2015;23:439-46. [DOI: 10.1177/1066896915582264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
76 Kothari S, Kalinowski M, Shah N, Raddawi H. A Case of Idiopathic Non-Cirrhotic Portal Hypertension in a Patient With a Left Ventricular Assist Device. J Investig Med High Impact Case Rep 2019;7:2324709619878337. [PMID: 31554434 DOI: 10.1177/2324709619878337] [Reference Citation Analysis]
77 Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071-1081. [PMID: 21574171 DOI: 10.1002/hep.24422] [Cited by in Crossref: 170] [Cited by in F6Publishing: 140] [Article Influence: 17.0] [Reference Citation Analysis]
78 Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Dig Liver Dis. 2018;50:839-844. [PMID: 29429910 DOI: 10.1016/j.dld.2018.01.132] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
79 Fan J, Chen CJ, Wang YC, Quan W, Wang JW, Zhang WG. Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice. World J Gastroenterol 2019; 25(11): 1355-1365 [PMID: 30918428 DOI: 10.3748/wjg.v25.i11.1355] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Fiel MI, Schiano T. A patient with no known liver disease presenting with a sentinel variceal hemorrhage. Hepatology 2009;49:335-335. [DOI: 10.1002/hep.22766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]